Search Results - "Quint, Marine"

Negative MRD at Day 100 after Allogenic Hematopoietic Stem Cell Transplant (HSCT): The Grail to Reach in Acute Myeloid Leukemia (AML) by DA Rocha, Audrey, Caulier, Alexis, Joris, Magalie, Charbonnier, Amandine, Sage, Mathieu, Merlusca, Lavinia, Montes, Lydia, Guillaume, Nicolas, Desoutter, Judith, Lacassagne, Marie-Noëlle, Quint, Marine, Boyer, Thomas, Harrivel, Véronique, Duployez, Nicolas, Marceau, Alice, Marolleau, Jean-Pierre, Lebon, Delphine

“…HSCT remains the best curative treatment in eligible AML patients with adverse or intermediate cytogenetics according to the ELN classification, and for those…”
Get full text

Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease by Lebon, Delphine, Dujardin, Adèle, Caulier, Alexis, Joris, Magalie, Charbonnier, Amandine, Gruson, Bérengère, Quint, Marine, Castelain, Sandrine, François, Catherine, Lacassagne, Marie-Noëlle, Guillaume, Nicolas, Marolleau, Jean-Pierre, Morel, Pierre

“…Steroid-refractory graft-versus-host disease (SR-GVHD) is a challenging complication of allogeneic hematopoietic stem cell transplantation, and leads to high…”
Get full text

Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment by Adèle, Dujardin, Morel, Pierre, Caulier, Alexis, Joris, Magalie, Charbonnier, Amandine, Gruson, Berengere, Quint, Marine, Lacassagne, Marie-Noëlle, Castelain, Sandrine, Marolleau, Jean-Pierre, Lebon, Delphine

“…Introduction: Corticosteroid-refractory graft-versus-host disease (GVHD) remains a serious complication of hematopoietic stem cell transplantation (HSCT) with…”
Get full text